Literature DB >> 19383284

The role of histone deacetylases (HDACs) in human cancer.

Santiago Ropero1, Manel Esteller.   

Abstract

The balance of histone acetylation and deacetylation is an epigenetic layer with a critical role in the regulation of gene expression. Histone acetylation induced by histone acetyl transferases (HATs) is associated with gene transcription, while histone hypoacetylation induced by histone deacetylase (HDAC) activity is associated with gene silencing. Altered expression and mutations of genes that encode HDACs have been linked to tumor development since they both induce the aberrant transcription of key genes regulating important cellular functions such as cell proliferation, cell-cycle regulation and apoptosis. Thus, HDACs are among the most promising therapeutic targets for cancer treatment, and they have inspired researchers to study and develop HDAC inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19383284      PMCID: PMC5543853          DOI: 10.1016/j.molonc.2007.01.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  63 in total

Review 1.  The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.

Authors:  G Christofori; H Semb
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

Review 2.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

3.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

4.  A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.

Authors:  Santiago Ropero; Mario F Fraga; Esteban Ballestar; Richard Hamelin; Hiroyuki Yamamoto; Manuel Boix-Chornet; Rosalia Caballero; Miguel Alaminos; Fernando Setien; Maria F Paz; Michel Herranz; Jose Palacios; Diego Arango; Torben F Orntoft; Lauri A Aaltonen; Simó Schwartz; Manel Esteller
Journal:  Nat Genet       Date:  2006-04-16       Impact factor: 38.330

5.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.

Authors:  Mario F Fraga; Esteban Ballestar; Ana Villar-Garea; Manuel Boix-Chornet; Jesus Espada; Gunnar Schotta; Tiziana Bonaldi; Claire Haydon; Santiago Ropero; Kevin Petrie; N Gopalakrishna Iyer; Alberto Pérez-Rosado; Enrique Calvo; Juan A Lopez; Amparo Cano; Maria J Calasanz; Dolors Colomer; Miguel Angel Piris; Natalie Ahn; Axel Imhof; Carlos Caldas; Thomas Jenuwein; Manel Esteller
Journal:  Nat Genet       Date:  2005-03-13       Impact factor: 38.330

6.  Increased expression of histone deacetylase 2 is found in human gastric cancer.

Authors:  Jaehwi Song; Ji Heon Noh; Jong Heun Lee; Jung Woo Eun; Young Min Ahn; Su Young Kim; Sug Hyung Lee; Won Sang Park; Nam Jin Yoo; Jung Young Lee; Suk Woo Nam
Journal:  APMIS       Date:  2005-04       Impact factor: 3.205

7.  HDAC6 expression is correlated with better survival in breast cancer.

Authors:  Zhenhuan Zhang; Hiroko Yamashita; Tatsuya Toyama; Hiroshi Sugiura; Yoko Omoto; Yoshiaki Ando; Keiko Mita; Maho Hamaguchi; Shin-Ichi Hayashi; Hirotaka Iwase
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

8.  Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer.

Authors:  Andrew J Wilson; Do-Sun Byun; Natalia Popova; Lucas B Murray; Kaitlin L'Italien; Yoshihiro Sowa; Diego Arango; Anna Velcich; Leonard H Augenlicht; John M Mariadason
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

Review 9.  Histone acetylation and gastrointestinal carcinogenesis.

Authors:  Wataru Yasui; Naohide Oue; Shigehiro Ono; Yoshitsugu Mitani; Reiko Ito; Hirofumi Nakayama
Journal:  Ann N Y Acad Sci       Date:  2003-03       Impact factor: 5.691

Review 10.  Histone deacetylase inhibitors: understanding a new wave of anticancer agents.

Authors:  Ana Villar-Garea; Manel Esteller
Journal:  Int J Cancer       Date:  2004-11-01       Impact factor: 7.396

View more
  304 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

Review 2.  Macrocyclic histone deacetylase inhibitors.

Authors:  Sandra C Mwakwari; Vishal Patil; William Guerrant; Adegboyega K Oyelere
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.

Authors:  William Guerrant; Vishal Patil; Joshua C Canzoneri; Adegboyega K Oyelere
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

4.  HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.

Authors:  Bizhan Romani; Nima Shaykh Baygloo; Mojtaba Hamidi-Fard; Mohammad Reza Aghasadeghi; Elham Allahbakhshi
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

5.  Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.

Authors:  L Li; R Fang; B Liu; H Shi; Y Wang; W Zhang; X Zhang; L Ye
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

Review 6.  Panobinostat: first global approval.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

7.  Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146.

Authors:  Shiv Prakash Verma; Ayushi Agarwal; Parimal Das
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-03-19       Impact factor: 2.416

8.  GDF11/BMP11 as a novel tumor marker for liver cancer.

Authors:  Yong-Hui Zhang; Lian-Hong Pan; Yi Pang; Jin-Xin Yang; Meng-Jia Lv; Feng Liu; Xue-Feng Qu; Xin-Xin Chen; Hua-Jun Gong; Dan Liu; Yong Wei
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

9.  Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.

Authors:  Jie Xia; Ermias Lemma Tilahun; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  Methods       Date:  2014-12-03       Impact factor: 3.608

10.  Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.

Authors:  Jin Li; Eric R Falcone; Sarah A Holstein; Amy C Anderson; Dennis L Wright; Andrew J Wiemer
Journal:  Pharmacol Res       Date:  2016-09-20       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.